Summary

Heart Valve Devices Market – Scope of Report
TMR’s report on the global heart valve devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global heart valve devices market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global heart valve devices market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the heart valve devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global heart valve devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global heart valve devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global heart valve devices market.

The report delves into the competitive landscape of the global heart valve devices market. Key players operating in the global heart valve devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global heart valve devices market profiled in this report.

Key Questions Answered in Global heart valve devices Market Report
• What is the sales/revenue generated by heart valve devices across all regions during the forecast period?
• What are the opportunities in the global heart valve devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Heart Valve Devices Market – Research Objectives and Research Approach
The comprehensive report on the global heart valve devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global heart valve devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global heart valve devices market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Heart Valve Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Heart Valve Devices Market Analysis and Forecasts, 2020-2034
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Insights on Global Burden of Cardiovascular Diseases
    5.2. Regulatory Landscape for Heart Valve Devices in Key Regions / Countries
    5.3. Overview on Cardiovascular Surgical Procedures
    5.4. Key Industry Events (Product Approvals, Partnerships, and Collaborations)
    5.5. Technological Advancements in the Field of Heart Valve Surgeries
    5.6. Reimbursement Scenario across Key Regions / Countries
    5.7. Pricing Trends of Heart Valve Devices
    5.8. PEST Analysis
    5.9. Key Product / Brand Analysis
    5.10. Insights on Global Burden of Cardiovascular Diseases
6. Global Heart Valve Devices Market Analysis and Forecasts, By Type of Heart Valve
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Type of Heart Valve, 2020-2034
        6.3.1. Aortic Valve
            6.3.1.1. Less than 20 mm
            6.3.1.2. 20-23 mm
            6.3.1.3. 23-26 mm
            6.3.1.4. More than 26 mm
        6.3.2. Mitral Valve
            6.3.2.1. Less than 26 mm
            6.3.2.2. 26-28 mm
            6.3.2.3. 29-31 mm
            6.3.2.4. More than 31 mm
        6.3.3. Tricuspid Valve
        6.3.4. Pulmonary Valve
    6.4. Market Attractiveness By Type of Heart Valve
7. Global Heart Valve Devices Market Analysis and Forecasts, By Material
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Material, 2020-2034
        7.3.1. Biological Valves
            7.3.1.1. TAVI
            7.3.1.2. Surgical
            7.3.1.3. Others
        7.3.2. Mechanical Valves
    7.4. Market Attractiveness By Material
8. Global Heart Valve Devices Market Analysis and Forecasts, By Age Group
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By Age Group, 2020-2034
        8.3.1. Pediatric Patients
        8.3.2. Adults
        8.3.3. Geriatric Patients
    8.4. Market Attractiveness By Age Group
9. Global Heart Valve Devices Market Analysis and Forecasts, By End-user
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast By End-user, 2020-2034
        9.3.1. Hospitals
        9.3.2. Ambulatory Surgical Centers
        9.3.3. Others
    9.4. Market Attractiveness By End-user
10. Global Heart Valve Devices Market Analysis and Forecasts, By Region
    10.1. Key Findings
    10.2. Market Value Forecast By Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Region
11. North America Heart Valve Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Type of Heart Valve, 2020-2034
        11.2.1. Aortic Valve
            11.2.1.1. Less than 20 mm
            11.2.1.2. 20-23 mm
            11.2.1.3. 23-26 mm
            11.2.1.4. More than 26 mm
        11.2.2. Mitral Valve
            11.2.2.1. Less than 26 mm
            11.2.2.2. 26-28 mm
            11.2.2.3. 29-31 mm
            11.2.2.4. More than 31 mm
        11.2.3. Tricuspid Valve
        11.2.4. Pulmonary Valve
    11.3. Market Value Forecast By Material, 2020-2034
        11.3.1. Biological Valves
            11.3.1.1. TAVI
            11.3.1.2. Surgical
            11.3.1.3. Others
        11.3.2. Mechanical Valves
    11.4. Market Value Forecast By Age Group, 2020-2034
        11.4.1. Pediatric Patients
        11.4.2. Adults
        11.4.3. Geriatric Patients
    11.5. Market Value Forecast By End-user, 2020-2034
        11.5.1. Hospitals
        11.5.2. Ambulatory Surgical Centers
        11.5.3. Others
    11.6. Market Value Forecast By Country, 2020-2034
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Type of Heart Valve
        11.7.2. By Material
        11.7.3. By Age Group
        11.7.4. By End-user
        11.7.5. By Country
12. Europe Heart Valve Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Type of Heart Valve, 2020-2034
        12.2.1. Aortic Valve
            12.2.1.1. Less than 20 mm
            12.2.1.2. 20-23 mm
            12.2.1.3. 23-26 mm
            12.2.1.4. More than 26 mm
        12.2.2. Mitral Valve
            12.2.2.1. Less than 26 mm
            12.2.2.2. 26-28 mm
            12.2.2.3. 29-31 mm
            12.2.2.4. More than 31 mm
        12.2.3. Tricuspid Valve
        12.2.4. Pulmonary Valve
    12.3. Market Value Forecast By Material, 2020-2034
        12.3.1. Biological Valves
            12.3.1.1. TAVI
            12.3.1.2. Surgical
            12.3.1.3. Others
        12.3.2. Mechanical Valves
    12.4. Market Value Forecast By Age Group, 2020-2034
        12.4.1. Pediatric Patients
        12.4.2. Adults
        12.4.3. Geriatric Patients
    12.5. Market Value Forecast By End-user, 2020-2034
        12.5.1. Hospitals
        12.5.2. Ambulatory Surgical Centers
        12.5.3. Others
    12.6. Market Value Forecast By Country / Sub-region, 2020-2034
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Spain
        12.6.5. Italy
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Type of Heart Valve
        12.7.2. By Material
        12.7.3. By Age Group
        12.7.4. By End-user
        12.7.5. By Country / Sub-region
13. Asia Pacific Heart Valve Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Type of Heart Valve, 2020-2034
        13.2.1. Aortic Valve
            13.2.1.1. Less than 20 mm
            13.2.1.2. 20-23 mm
            13.2.1.3. 23-26 mm
            13.2.1.4. More than 26 mm
        13.2.2. Mitral Valve
            13.2.2.1. Less than 26 mm
            13.2.2.2. 26-28 mm
            13.2.2.3. 29-31 mm
            13.2.2.4. More than 31 mm
        13.2.3. Tricuspid Valve
        13.2.4. Pulmonary Valve
    13.3. Market Value Forecast By Material, 2020-2034
        13.3.1. Biological Valves
            13.3.1.1. TAVI
            13.3.1.2. Surgical
            13.3.1.3. Others
        13.3.2. Mechanical Valves
    13.4. Market Value Forecast By Age Group, 2020-2034
        13.4.1. Pediatric Patients
        13.4.2. Adults
        13.4.3. Geriatric Patients
    13.5. Market Value Forecast By End-user, 2020-2034
        13.5.1. Hospitals
        13.5.2. Ambulatory Surgical Centers
        13.5.3. Others
    13.6. Market Value Forecast By Country / Sub-region, 2020-2034
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Type of Heart Valve
        13.7.2. By Material
        13.7.3. By Age Group
        13.7.4. By End-user
        13.7.5. By Country / Sub-region
14. Latin America Heart Valve Devices Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Type of Heart Valve, 2020-2034
        14.2.1. Aortic Valve
            14.2.1.1. Less than 20 mm
            14.2.1.2. 20-23 mm
            14.2.1.3. 23-26 mm
            14.2.1.4. More than 26 mm
        14.2.2. Mitral Valve
            14.2.2.1. Less than 26 mm
            14.2.2.2. 26-28 mm
            14.2.2.3. 29-31 mm
            14.2.2.4. More than 31 mm
        14.2.3. Tricuspid Valve
        14.2.4. Pulmonary Valve
    14.3. Market Value Forecast By Material, 2020-2034
        14.3.1. Biological Valves
            14.3.1.1. TAVI
            14.3.1.2. Surgical
            14.3.1.3. Others
        14.3.2. Mechanical Valves
    14.4. Market Value Forecast By Age Group, 2020-2034
        14.4.1. Pediatric Patients
        14.4.2. Adults
        14.4.3. Geriatric Patients
    14.5. Market Value Forecast By End-user, 2020-2034
        14.5.1. Hospitals
        14.5.2. Ambulatory Surgical Centers
        14.5.3. Others
    14.6. Market Value Forecast By Country / Sub-region, 2020-2034
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Type of Heart Valve
        14.7.2. By Material
        14.7.3. By Age Group
        14.7.4. By End-user
        14.7.5. By Country / Sub-region
15. Middle East & Africa Heart Valve Devices Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast By Type of Heart Valve, 2020-2034
        15.2.1. Aortic Valve
            15.2.1.1. Less than 20 mm
            15.2.1.2. 20-23 mm
            15.2.1.3. 23-26 mm
            15.2.1.4. More than 26 mm
        15.2.2. Mitral Valve
            15.2.2.1. Less than 26 mm
            15.2.2.2. 26-28 mm
            15.2.2.3. 29-31 mm
            15.2.2.4. More than 31 mm
        15.2.3. Tricuspid Valve
        15.2.4. Pulmonary Valve
    15.3. Market Value Forecast By Material, 2020-2034
        15.3.1. Biological Valves
            15.3.1.1. TAVI
            15.3.1.2. Surgical
            15.3.1.3. Others
        15.3.2. Mechanical Valves
    15.4. Market Value Forecast By Age Group, 2020-2034
        15.4.1. Pediatric Patients
        15.4.2. Adults
        15.4.3. Geriatric Patients
    15.5. Market Value Forecast By End-user, 2020-2034
        15.5.1. Hospitals
        15.5.2. Ambulatory Surgical Centers
        15.5.3. Others
    15.6. Market Value Forecast By Country / Sub-region, 2020-2034
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Type of Heart Valve
        15.7.2. By Material
        15.7.3. By Age Group
        15.7.4. By End-user
        15.7.5. By Country / Sub-region
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of companies)
    16.2. Company Profiles
        16.2.1. Medtronic plc
            16.2.1.1. Company Overview
            16.2.1.2. Financial Overview
            16.2.1.3. Product Portfolio
            16.2.1.4. Business Strategies
            16.2.1.5. Recent Developments
        16.2.2. Boston Scientific Corporation
            16.2.2.1. Company Overview
            16.2.2.2. Financial Overview
            16.2.2.3. Product Portfolio
            16.2.2.4. Business Strategies
            16.2.2.5. Recent Developments
        16.2.3. Abbott
            16.2.3.1. Company Overview
            16.2.3.2. Financial Overview
            16.2.3.3. Product Portfolio
            16.2.3.4. Business Strategies
            16.2.3.5. Recent Developments
        16.2.4. Edwards Lifesciences Corporation
            16.2.4.1. Company Overview
            16.2.4.2. Financial Overview
            16.2.4.3. Product Portfolio
            16.2.4.4. Business Strategies
            16.2.4.5. Recent Developments
        16.2.5. Foldax Inc.
            16.2.5.1. Company Overview
            16.2.5.2. Financial Overview
            16.2.5.3. Product Portfolio
            16.2.5.4. Business Strategies
            16.2.5.5. Recent Developments
        16.2.6. Novostia SA
            16.2.6.1. Company Overview
            16.2.6.2. Financial Overview
            16.2.6.3. Product Portfolio
            16.2.6.4. Business Strategies
            16.2.6.5. Recent Developments
        16.2.7. Meril Life Sciences Pvt. Ltd.
            16.2.7.1. Company Overview
            16.2.7.2. Financial Overview
            16.2.7.3. Product Portfolio
            16.2.7.4. Business Strategies
            16.2.7.5. Recent Developments
        16.2.8. Corcym UK Limited
            16.2.8.1. Company Overview
            16.2.8.2. Financial Overview
            16.2.8.3. Product Portfolio
            16.2.8.4. Business Strategies
            16.2.8.5. Recent Developments
        16.2.9. JenaValve Technology, Inc.
            16.2.9.1. Company Overview
            16.2.9.2. Financial Overview
            16.2.9.3. Product Portfolio
            16.2.9.4. Business Strategies
            16.2.9.5. Recent Developments
        16.2.10. Micro Interventional Devices, Inc.
            16.2.10.1. Company Overview
            16.2.10.2. Financial Overview
            16.2.10.3. Product Portfolio
            16.2.10.4. Business Strategies
            16.2.10.5. Recent Developments
        16.2.11. Auto Tissue Berlin GmbH
            16.2.11.1. Company Overview
            16.2.11.2. Financial Overview
            16.2.11.3. Product Portfolio
            16.2.11.4. Business Strategies
            16.2.11.5. Recent Developments
        16.2.12. Anteris Technologies Ltd
            16.2.12.1. Company Overview
            16.2.12.2. Financial Overview
            16.2.12.3. Product Portfolio
            16.2.12.4. Business Strategies
            16.2.12.5. Recent Developments
        16.2.13. Thubrikar Aortic Valve, Inc.
            16.2.13.1. Company Overview
            16.2.13.2. Financial Overview
            16.2.13.3. Product Portfolio
            16.2.13.4. Business Strategies
            16.2.13.5. Recent Developments
        16.2.14. MicroPort Scientific Corporation
            16.2.14.1. Company Overview
            16.2.14.2. Financial Overview
            16.2.14.3. Product Portfolio
            16.2.14.4. Business Strategies
            16.2.14.5. Recent Developments
        16.2.15. Biosensors International Group, Ltd.
            16.2.15.1. Company Overview
            16.2.15.2. Financial Overview
            16.2.15.3. Product Portfolio
            16.2.15.4. Business Strategies
            16.2.15.5. Recent Developments